Scripta Therapeutics
Scripta Therapeutics is an Oxford-based techbio company that takes a biology-first approach to discover disease-modifying drugs that modulate transcription factor activity and reprogram biology.
Scripta Therapeutics has raised €10M across 1 funding round from 6 investors, most recently a Seed round in Nov 2025. Based in Oxford, UK; active in Healthtech. Data as of 28 Oct 2026.
Oxford, UKwww.scriptatherapeutics.com ↗
Total raised
€10M
€10,300,000
Funding rounds
1
Investors
6
distinct backers
Active since
2025-11
latest 2025-11
Funding by year
EUR raised per yearScripta Therapeutics — funding by year — interactive chart.
Data table
| Scripta Therapeutics — funding by year | |
|---|---|
| 2025 | €10M |
Signals
High confidenceRaise-next likelihood60
base rate 44% for Seed
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-11-13 | Seed | €10M | AlbionVC,Apollo Health Ventures,Oxford Science Enterprises (OSE),Oxford University Innovation Fund,Parkwalk Advisors,YZR Capital | View deal → |